Workflow
超高清LED显示
icon
Search documents
北国春城 “吉”聚动能!政媒企联动共探新材料与医药产业发展新机遇
Sou Hu Cai Jing· 2025-09-21 04:26
Core Viewpoint - The "2025 Changchun New Materials and Pharmaceutical Industry Exchange Conference" held in Changchun aims to explore new cooperation opportunities and innovative development paths in the context of global technological innovation and industrial transformation [4][5]. Group 1: Event Overview - The conference was organized by the China Investment Association, Shanghai Securities Journal, and the Changchun New Area Management Committee, gathering over a hundred executives from listed companies, strong enterprises, financial institutions, and experts from renowned universities [4]. - The event included site visits and in-depth discussions to foster collaboration among participants [4]. Group 2: Industry Development - New materials and biomedicine are recognized as strategic emerging industries that drive high-quality economic development [4]. - Changchun, as a significant old industrial base in China, has shown strong growth in biomedicine, chemical new materials, and advanced equipment manufacturing [4][5]. Group 3: Economic Performance - In the first half of the year, Changchun New Area's GDP grew by 6.4%, and the industrial added value increased by 9.7%, with the pharmaceutical and optical information industries growing by 16.5% and 15.4%, respectively [5]. - The pharmaceutical health industry in Changchun New Area has surpassed a scale of 50 billion yuan [32]. Group 4: Government and Institutional Support - The Changchun municipal government is committed to integrating into the provincial industrial development framework and promoting the construction of the Yongchun Biomedical City and Beihu Future Science City [8]. - The Shanghai Securities Journal aims to leverage its resources to support the development of Changchun New Area, focusing on industry chain investment and collaboration [25]. Group 5: Innovation and Collaboration - The conference highlighted the importance of integrating innovation chains, industry chains, and capital chains to promote technological breakthroughs and collaborative innovation ecosystems [28]. - Various representatives expressed their willingness to collaborate in areas such as pharmaceutical research and development, production, and new materials applications [39][42].